MorrisKletzelMD
Pediatric Hematology & Oncology • Highland Park, ILProfessor in Pediatrics, Northwestern University Medical School
Dr. Kletzel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
324 Leonard wood s apt 201
Highland Park, IL 60035Phone+1 773-456-3341
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1980- University of Texas Health Science Center at HoustonResidency, Pediatrics, 1978 - 1979
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1975 - 1978
Universidad Nacional Autonoma de MexicoClass of 1972
Certifications & Licensure
IL State Medical License 1991 - 2023
AR State Medical License 1985 - 2000- American Board of Pediatrics Pediatrics
Clinical Trials
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) Start of enrollment: 2000 Mar 10
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors Start of enrollment: 1999 Apr 01
- WT1 for the Detection of Minimal Residual Disease Start of enrollment: 1999 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsAssociation Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablat...Tim Bognàr, Imke H Bartelink, Toine C G Egberts, Carin M A Rademaker, A Birgitta Versluys
Transplantation and Cellular Therapy. 2022-04-01 - 4 citationsReduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-ri...Jenna Rossoff, David A. Jacobsohn, Soyang Kwon, Morris Kletzel, Reggie E. Duerst
Pediatric Blood & Cancer. 2021-05-22 - 16 citationsVeno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.Tal Schechter, Evelio Perez-Albuerne, Tiffany F. Lin, Meredith S. Irwin, Mohammed Sh. Essa
Bone Marrow Transplantation. 2020-03-01
Journal Articles
- Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in NeuroblastomaGregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature
Abstracts/Posters
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyMorris Kletzel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyMorris Kletzel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
